Hormone replacement therapy (HRT), also known as menopausal hormone therapy (MHT) or postmenopausal hormone therapy (PHT, PMHT), is a form of hormone therapy which is used to treat symptoms associated with menopause in women.These symptoms can include hot flashes, vaginal atrophy and dryness, and bone loss, among others, and are caused by diminished levels of sex hormones in the menopausal period.The main hormonal medications used in HRT for menopausal symptoms are estrogens and progestogens.A progestogen is usually used in combination with an estrogen in women with intact uteruses because unopposed estrogen therapy is associated with endometrial hyperplasia and cancer and progestogens prevent these risks.Androgens like testosterone are sometimes used in HRT as well.HRT medications are available in various forms and for use by a variety of different routes of administration.
Based on the Hormone Replacement Therapy (HRT) market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.
In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.
Key players in the global Hormone Replacement Therapy (HRT) market covered in Chapter 5:
Novartis
Pfizer
Abbott Laboratories
Bayer
Amgen
Eli Lily
Wyeth
Novo Nordisk
Merck & Co.
Genentech
Mylan Laboratories
In Chapter 6, on the basis of types, the Hormone Replacement Therapy (HRT) market from 2015 to 2025 is primarily split into:
Oral
Parenteral
Transdermal
Others
In Chapter 7, on the basis of applications, the Hormone Replacement Therapy (HRT) market from 2015 to 2025 covers:
Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Hormone Replacement Therapy (HRT). Industry analysis & Market Report on Hormone Replacement Therapy (HRT) is a syndicated market report, published as Global Hormone Replacement Therapy (HRT) Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery. It is complete Research Study and Industry Analysis of Hormone Replacement Therapy (HRT) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.